"The Pearson Center for Alcoholism & Addiction Research of La Jolla, CA, was co-founded by Dr. Barbara J. Mason and Dr. George F. Koob, and is part of the Scripps Research Institute, which is one of the world leaders in the biomedical science of alcoholism, addiction, and the brain. Established in 2003 in La Jolla, California through the generosity of a multi-million dollar gift, The Pearson Center is a research foundation that uses the latest biomedical research with clinical treatments to fight the deadly disease of alcohol and drug addiction. Our main clinical studies focus on alcoholism and binge drinking."

During the past decade, The Scripps Research Institute Pearson Center for Alcoholism and Addiction Research conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Scripps Research Institute Pearson Center for Alcoholism and Addiction Research" #1 collaborator was "National Institute on Alcohol Abuse and Alcoholism (NIAAA)" with 4 trials as a collaborator and "Mapreg" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "The Scripps Research Institute Pearson Center for Alcoholism and Addiction Research" are "Alcohol Use Disorder" (3 trials) and "Alcohol Dependence" (1 trials). Many other conditions were trialed in "The Scripps Research Institute Pearson Center for Alcoholism and Addiction Research" in a lesser frequency.

Most popular intervention types in "The Scripps Research Institute Pearson Center for Alcoholism and Addiction Research" are "Drug" (4 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Apremilast" (1 trials), "Duloxetine" (1 trials), "MAP4343" (1 trials) and "Miricorilant" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Scripps Research Institute Pearson Center for Alcoholism and Addiction Research" are 4 trials for "All" genders.

Currently, there are NaN active trials in "The Scripps Research Institute Pearson Center for Alcoholism and Addiction Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in The Scripps Research Institute Pearson Center for Alcoholism and Addiction Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The Scripps Research Institute Pearson Center for Alcoholism and Addiction Research, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".